Physician
Nephrology
Dr. Lee A. Hebert, MD
|
|
Give Review
Hebert practices Nephrology. He researched medicine at Medical College of Wisconsin. Medical College of Wisconsin has a rank of 54 in research and a 62 in primary care He has 1 awards "CMS Meaningful Use Stage 1 Certification". Lee A. Hebert is a published physician as well. He has 59 publications published. The latest was: Intensive Supportive Care plus Immunosuppression in IgA Nephropathy. Hebert is registered with Medicare.
Publications
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.
- The Complement System in Lupus Nephritis.
- Is Fluid Overload as Measured by Bioimpedance Spectroscopy Harmful in CKD-If So, Why?
- Oral Warfarin and the Thrombin Inhibitor Dabigatran Increase Blood Pressure in Rats: Hidden Danger of Anticoagulants?
- End-Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1.
- Renal Flare as a Predictor of Incident and Progressive CKD in Patients with Lupus Nephritis.
- A Within-Patient Analysis for Time-Varying Risk Factors of CKD Progression.
- Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of Chronic glomerular disease.
- End-stage Kidney disease in African Americans with lupus nephritis associates with APOL1.
- Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with Acute kidney injury in rats.
- Chronic Kidney disease: Fluid in chronic Kidney disease-how much is too much?
- Progressive renal light chain Amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloi...
- When Size Matters: Diagnostic Value of Kidney Biopsy according to the Gauge of the Biopsy Needle.
- Lupus Nephritis: induction therapy in severe lupus Nephritis--should MMF be considered the drug of choice?
- IgG subclass staining in renal biopsies with membranous Glomerulonephritis indicates subclass switch during disease progression.
- Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus.
- Evidence that abnormally large seasonal declines in Vitamin D status may trigger SLE flare in non-African Americans.
- Benefit of cyclophosphamide therapy in IgA Nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole...
- Warfarin-Related Nephropathy Modeled by Nephron Reduction and Excessive Anticoagulation.
- Relapse or Worsening of Nephrotic Syndrome in Idiopathic Membranous Nephropathy Can Occur even though the Glomerular Immune Deposits Have Been Eradicated.
- Infection-related Glomerulonephritis: understanding mechanisms.
- Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with Disease activity, vascular risk factors and atherosclerosis.
- A modest proposal for improving the accuracy of creatinine-based GFR estimating equations.
- An approach to validate criteria for proteinuric flare in systemic lupus erythematosus Glomerulonephritis.
- Warfarin-related nephropathy occurs in patients with and without chronic Kidney disease and is associated with an increased mortality rate.
- Measured GFR has limited clinical utility.
- Rituximab or cyclophosphamide in ANCA-associated Renal vasculitis.
- Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis.
- Oral cyclophosphamide for lupus Glomerulonephritis: an underused therapeutic option.
- D-dimer level and the risk for thrombosis in systemic lupus erythematosus.
- Biomarkers of lupus Nephritis determined by serial urine proteomics.
- Relationship between albuminuria and total proteinuria in systemic lupus erythematosus Nephritis: diagnostic and therapeutic implications.
- Sensitive and specific real-time polymerase chain reaction assays to accurately determine copy number variations (CNVs) of human complement C4A, C4B, C4-long, C4-short...
- Typing of Amyloidosis in renal biopsies: diagnostic pitfalls.
- Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for an...
- A dinucleotide deletion in CD24 confers protection against autoimmune Diseases.
- Association of a common complement receptor 2 haplotype With increased risk of systemic lupus erythematosus.
- Biomarker discovery in human SLE Nephritis.
- Fluctuation in self-perceived stress and increased risk of flare in patients With lupus nephritis carrying the serotonin receptor 1A -1019 G allele.
- Measured and estimated glomerular filtration rate.
- My doctor said I should drink a lot! Recommendations for fluid intake in patients with chronic Kidney disease.
- Proposed pathogenesis of idiopathic loin pain-hematuria syndrome.
- Optimizing ACE-inhibitor therapy for chronic Kidney disease.
- Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein le...
- Timed urine collections are not needed to measure urine protein excretion in clinical practice.
- Plasma, urine, and Renal expression of adiponectin in human systemic lupus erythematosus.
- Should the target for blood pressure control specify both a systolic and a diastolic component?
- Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemi...
- Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy.
- Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy With strong risk factors for progression.
- Urine chemokines as biomarkers of human systemic lupus erythematosus activity.
- Mycophenolate therapy of SLE membranous Nephropathy.
- An unusual cause of gross hematuria and transient ARF in an SLE patient With warfarin coagulopathy.
- Mycophenolate therapy in frequently relapsing minimal change Disease that has failed cyclophosphamide therapy.
- Management of glomerular Proteinuria: a commentary.
- High urine volume and low urine osmolality are risk factors for faster progression of renal Disease.
- Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases.
- Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach.
Schools
Marquette School Of Medicine
Seton Hall Jersey City Med
Marquette University Milwaukee Co
Tufts University
Conditions Treated
- Acute GlomeruloNephritis
- Acute Kidney Failure
- Amyloidosis
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Tufts Medical Center -
Medical College of Wisconsin
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1124035522 | |
| NPPES Provider LastName | HEBERT | |
| NPPES Provider FirstName | LEE | |
| NPPES Provider ZIPCode | 432101240 | |
| NPPES Provider State | OH | |
| Specialty Description | Nephrology | |
| Total Claim Count | 780.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 98.0 | |
| Percent Opioid Claims | 12.56 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124035522 |
| Last Name Of The Provider | HEBERT |
| First Name Of The Provider | LEE |
| View All |
Similar Doctors
|
|
Dr. Uday S. Nori, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rosemarie L. Shim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason M. Prosek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher S. Saunders, MD |
|
|
Dr. Melkon O. Hajinazarian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Stacie D. Hemmert, LD |